Cotellic Interactions
There are 404 drugs known to interact with Cotellic (cobimetinib), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 124 are major, and 280 are moderate.
- View all 404 medications that may interact with Cotellic
- View Cotellic alcohol/food interactions (1)
- View Cotellic disease interactions (7)
Most frequently checked interactions
View interaction reports for Cotellic (cobimetinib) and the medicines listed below.
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Aspirin Low Strength (aspirin)
- atorvastatin
- Biaxin (clarithromycin)
- bleomycin
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Cosentyx (secukinumab)
- Eltroxin (levothyroxine)
- Esbriet (pirfenidone)
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Lyrica (pregabalin)
- Mekinist (trametinib)
- metformin
- Nexium (esomeprazole)
- Nydrazid (isoniazid)
- Oncovin (vincristine)
- Procysbi (cysteamine)
- Promacta (eltrombopag)
- Sabril (vigabatrin)
- Sandimmune (cyclosporine)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tafinlar (dabrafenib)
- tamsulosin
- Tecentriq (atezolizumab)
- Trecator-SC (ethionamide)
- Zelboraf (vemurafenib)
Cotellic alcohol/food interactions
There is 1 alcohol/food interaction with Cotellic (cobimetinib).
Cotellic disease interactions
There are 7 disease interactions with Cotellic (cobimetinib) which include:
- cardiomyopathy
- hepatotoxicity
- ocular toxicities
- rhabdomyolysis
- lung toxicity
- liver dysfunction
- renal impairment
More about Cotellic (cobimetinib)
- Cotellic consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Caprelsa
Caprelsa (vandetanib) is used to treat thyroid cancer that cannot be removed by surgery or that has ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.